Point72 Middle East FZE’s Bristol-Myers Squibb BMY Stock Holding History

Point72 Middle East FZE’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-49,800	Closed	-$2.56M	–	188
2023 Q4	$2.56M	Sell	49,800 -51,300	-51%	-$2.69M	0.08%	344
2023 Q3	$5.87M	Buy	101,100 +59,100	+141%	+$3.62M	0.19%	136
2023 Q2	$2.69M	Buy	42,000 +30,500	+265%	+$2.05M	0.07%	316
2023 Q1	$797K	Sell	11,500 -41,400	-78%	-$2.92M	0.03%	577
2022 Q4	$3.81M	Buy	+52,900	New	+$3.99M	0.17%	149

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Middle East FZE's BMY Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 102,444 shares — an estimated $6.28M sold.

Point72 Middle East FZE first reported a position in BMY in Q2 2023 and held it in 1 quarter. The position peaked at $6.55M in Q2 2023. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Point72 Middle East FZE reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Point72 Middle East FZE sold 102,444 Bristol-Myers Squibb shares in Q3 2023, an estimated $6.28M.
Point72 Middle East FZE first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 1 quarter.
Point72 Middle East FZE's Bristol-Myers Squibb position peaked at $6.55M in Q2 2023.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.